{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:05:13Z","timestamp":1756191913300,"version":"3.37.3"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007469","name":"Alfred Benzon Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.pdpdt.2024.104211","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T15:36:27Z","timestamp":1715268987000},"page":"104211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effects of iron supplements in individuals with erythropoietic protoporphyria"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-875X","authenticated-orcid":false,"given":"Ida M.","family":"Heerfordt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina M.","family":"Lerche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Philipsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Christian","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.pdpdt.2024.104211_bib0001","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104211_bib0002","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/bjd.15050","article-title":"Protoporphyrin IX in the skin measured noninvasively predicts photosensitivity in patients with erythropoietic protoporphyria","volume":"175","author":"Heerfordt","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2024.104211_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.112054","article-title":"Light-provoked skin symptoms on the hands of erythropoietic protoporphyria patients related to personal dosimeter measurements, skin symptoms, light protection and priming","volume":"213","author":"Heerfordt","year":"2020","journal-title":"J. Photochem. Photobiol. B"},{"issue":"8","key":"10.1016\/j.pdpdt.2024.104211_bib0004","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","article-title":"Clinical, biochemical, and genetic characterization of north American patients with erythropoietic protoporphyria and X-linked Protoporphyria","volume":"153","author":"Balwani","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"2","key":"10.1016\/j.pdpdt.2024.104211_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/phpp.12727","article-title":"Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria","volume":"38","author":"Genovese","year":"2022","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104211_bib0006","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"C-Terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload","volume":"83","author":"Whatley","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104211_bib0007","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2796.2010.02236.x","article-title":"Erythropoietic protoporphyria in Sweden: demographic, clinical, biochemical and genetic characteristics","volume":"269","author":"Wahlin","year":"2011","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.pdpdt.2024.104211_bib0008","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2340\/00015555-3184","article-title":"Erythropoietic protoporphyria in a Japanese population","volume":"99","author":"Mizawa","year":"2019","journal-title":"Acta. Derm. Venereol."},{"issue":"10270","key":"10.1016\/j.pdpdt.2024.104211_bib0009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.pdpdt.2024.104211_bib0010","first-page":"33","article-title":"A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria","author":"Balwani","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.pdpdt.2024.104211_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114132","article-title":"Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: a systematic review","volume":"158","author":"Heerfordt","year":"2023","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.pdpdt.2024.104211_bib0012","article-title":"Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria","author":"Dickey","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104211_bib0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcmd.2014.07.017","article-title":"In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability","volume":"54","author":"Barman-Aks\u00f6zen","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104211_bib0014","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2133.1990.tb08293.x","article-title":"Erythropoietic protoporphyria and iron therapy","volume":"122","author":"McClements","year":"1990","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104211_bib0015","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jama.1970.03180060038008","article-title":"Erythropoietic protoporphyria. A clinical and genetic study","volume":"214","author":"Reed","year":"1970","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pdpdt.2024.104211_bib0016","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/bjh.12485","article-title":"Clinical and biochemical improvement following low-dose intravenous iron therapy in a patient with erythropoietic protoporphyria","volume":"163","author":"Bentley","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104211_bib0017","first-page":"610","article-title":"Erythropoietic protoporphyria provoked by iron therapy","volume":"64","author":"Baker","year":"1971","journal-title":"Proc. R. Soc. Med."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104211_bib0018","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/014107688407700316","article-title":"Histiocytosis X and erythropoietic protoporphyria","volume":"77","author":"Graham-Brown","year":"1984","journal-title":"J. R. Soc. Med."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104211_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-105-1-27","article-title":"Iron therapy for hepatic dysfunction in erythropoietic protoporphyria","volume":"105","author":"Gordeuk","year":"1986","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104211_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1988.tb07102.x","article-title":"Erythropoietic protoporphyria exacerbated by oral iron therapy","volume":"119","author":"Milligan","year":"1988","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"10.1016\/j.pdpdt.2024.104211_bib0021","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/cup.12215","article-title":"Leukocytoclastic vasculitis masking chronic vascular changes in previously undiagnosed erythropoietic protoporphyria","volume":"40","author":"Thom","year":"2013","journal-title":"J. Cutan. Pathol."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104211_bib0022","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.13612","article-title":"X-linked protoporphyria: iron supplementation improves protoporphyrin overload, liver damage and anaemia","volume":"173","author":"Landefeld","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104211_bib0023","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jaad.2006.11.030","article-title":"Symptomatic response of erythropoietic protoporphyria to iron supplementation","volume":"56","author":"Holme","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2024.104211_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1306.001","article-title":"Iron metabolism and the IRE\/IRP regulatory system: an update","volume":"1012","author":"Pantopoulos","year":"2004","journal-title":"Ann. N Y Acad. Sci."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100024002497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100024002497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T19:49:44Z","timestamp":1719863384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100024002497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":24,"alternative-id":["S1572100024002497"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104211","relation":{},"ISSN":["1572-1000"],"issn-type":[{"type":"print","value":"1572-1000"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of iron supplements in individuals with erythropoietic protoporphyria","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104211"}}